Delivery Order SPE2DB20D3111-SPE2DB25FA7CQ

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3101 and SPE2DB25FQVK5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,635.67 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMCBJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.65 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $11,537.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of May 31, 2024. This is a firm-fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.65, is a firm fixed-price delivery order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award, with ID SPE2DB20D1109|SPE2DB23FP11Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,792.89, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of May 12, 2023. The contract is not designated as a set-aside....
This federal contract award, SPE2DB24D1104|SPE2DB25FXTM7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,106.18, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL14D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,401.76, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract was awarded as a Delivery Order under a Firm Fixed Price pricing arrangement, with a performance period ending on January 14, 2025. This contract is...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRMX0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $18,141.37 and a completion date of June 17, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTGH4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,603.60, is a Firm Fixed Price Delivery Order for the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT7T8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $7,514.04 and an ultimate completion date of January 13, 2025. This award is not...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA7CQ
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3111|SPE2DB25FA7CQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,801.80, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 14, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/12/25, 9:54 AM